Benchmarking Synthetic Biology Product Development
Lead organization: University of California, Berkeley
Project partners: R2DIO, Antheia, Geno, Amyris, Oobli
Year launched: 2022
This project will elevate the commercial readiness of bioproducts throughout the bioindustrial manufacturing ecosystem by benchmarking performance and best practices in product development at BioMADE member companies. Researchers will make R&D performance dimensions more measurable, so as to make the commercial readiness of bioproducts and capabilities of the bioindustrial manufacturing workforce easier to understand and improve. This project will use the proven approach to benchmarking of define, measure, analyze, and improve. Specific, operational metrics of performance in R&D and the progression to manufacturing readiness will be formulated by the research team. Ultimately, this project will enable synthetic biology companies to understand achievable metric scores and to accelerate their adoption of best practices, in turn accelerating product development and compressing time to manufacturing readiness throughout the industry.
Funding source: BioMADE Project Call 2.0
Related News: